Inherited cardiomyopathies

New England Journal of Medicine

Volumn 330, Issue 13, 1994, Pages 913-919

  Epstein, Franklin H ^a   Kelly, Daniel P ^b   Strauss, Arnold W ^b  

^a Washington University School of Medicine ^*

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; CARNITINE; MYOSIN HEAVY CHAIN;

BECKER MUSCULAR DYSTROPHY; CARDIOMYOPATHY; CLINICAL FEATURE; DUCHENNE MUSCULAR DYSTROPHY; ENERGY METABOLISM; FAMILIAL DISEASE; FATTY ACID OXIDATION; GENE MAPPING; GENE MUTATION; HEART MUSCLE METABOLISM; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INBORN ERROR OF METABOLISM; MITOCHONDRIAL RESPIRATION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; X CHROMOSOME LINKED DISORDER;

CARDIOMYOPATHIES; CARDIOMYOPATHY, HYPERTROPHIC; ENERGY METABOLISM; FATTY ACIDS; HUMANS; LIPID METABOLISM, INBORN ERRORS; MITOCHONDRIA, HEART; MUSCULAR DYSTROPHIES; MYOSINS; OXIDATION-REDUCTION; PHOSPHORYLATION;

EID: 0028347574     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199403313301308     Document Type: Review

References (65)

1. Manolio TA, Baughman KL, Rodeheffer R, Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop). Am J Cardiol 1992; 69: 1458-1466
2. Michels VV, Moll PP, Miller FA, The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 1992; 326: 77-82
3. Graber HL, Unverferth DV, Baker PB, Ryan JM, Baba N, Wooley CF Evolution of a hereditary cardiac conduction and muscle disorder: a study involving a family with six generations affected. Circulation 1986; 74: 21-35
4. Berko BA, Swift M X-linked dilated cardiomyopathy. N Engl J Med 1987; 316: 1186-1191
5. Mestroni L, Miani D, Di Lenarda A, Clinical and pathologic study of familial dilated cardiomyopathy. Am J Cardiol 1990; 65: 1449-1453
6. Neely JR, Rovetto MJ, Oram JF Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 1972; 15: 289-329
7. Roe CR, Coates PM. Acyl-CoA dehydrogenase deficiencies. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. 6th ed. Vol. I. New York: McGraw-Hill, 1989:889-914.
8. Coates PM. Historical perspective of medium-chain acyl-CoA dehydrogenase deficiency: a decade of discovery. In: Coates PM, Tanaka K, eds. New developments in fatty acid oxidation. New York: Wiley-Liss, 1992:409-23.
9. Tein I, De Vivo DC, Bierman F, Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy. Pediatr Res 1990; 28: 247-255
10. Stanley CA, Hale DE, Berry GT, Deleeuw S, Boxer J, Bonnefont J-P A deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane. N Engl J Med 1992; 327: 19-23
11. Hug G, Bove KE, Soukup S Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II. N Engl J Med 1991; 325: 1862-1864
12. Taroni F, Verderio E, Fiorucci S, Molecular characterization of inherited carnitine palmitoyltransferase II deficiency. Proc Natl Acad Sci U S A 1992; 89: 8429-8433
13. Hale DE, Batshaw ML, Coates PM, Long-chain acyl coenzyme A dehydrogenase deficiency: an inherited cause of nonketotic hypoglycemia. Pediatr Res 1985; 19: 666-671
14. Rocchiccioli F, Wanders RJA, Aubourg P, Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood. Pediatr Res 1990; 28: 657-662
15. Duran M, Hofkamp M, Rhead WJ, Saudubray JM, Wadman SK Sudden child death and healthy' affected family members with medium-chain acyl-coenzyme A dehydrogenase deficiency. Pediatrics 1986; 78: 1052-1057
16. Corr PB, Creer MH, Yamada KA, Saffitz JE, Sobel BE Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest 1989; 83: 927-936
17. Matsubara Y, Narisawa K, Miyabayashi S, Tada K, Coates PM Molecular lesion in patients with medium-chain acyl-CoA dehydrogenase deficiency. Lancet 1990; 335: 1589-1589
18. Yokota I, Indo Y, Coates PM, Tanaka K Molecular basis of medium chain acyl-coenzyme A dehydrogenase deficiency: an A to G transition at position 985 that causes a lysine-304 to glutamate substitution in the mature protein is the single prevalent mutation. J Clin Invest 1990; 86: 1000-1003
19. Kelly DP, Whelan AJ, Ogden ML, Molecular characterization of inherited medium-chain acyl-CoA dehydrogenase deficiency. Proc Natl Acad Sci U S A 1990; 87: 9236-9240
20. Gregersen N, Andresen BS, Bross P, Molecular characterization of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: identification of a lys329 to glu mutation in the MCAD gene, and expression of inactive mutant enzyme protein in E. coli. Hum Genet 1991; 86: 545-551
21. Naito E, Ozasa H, Ikeda Y, Tanaka K Molecular cloning and nucleotide sequence of complementary DNAs encoding human short chain acyl-coenzyme A dehydrogenase and the study of the molecular basis of human short chain acyl-coenzyme A dehydrogenase deficiency. J Clin Invest 1989; 83: 1605-1613
22. Tanaka K, Yokota I, Coates PM, Mutations in the medium chain acyl-CoA dehydrogenase (MCAD) gene. Hum Mutat 1992; 1: 271-279
23. Naito E, Indo Y, Tanaka K Identification of two variant short chain acyl-coenzyme A dehydrogenase alleles, each containing a different point mutation in a patient with short chain acyl-coenzyme A dehydrogenase deficiency. J Clin Invest 1990; 85: 1575-1582
24. Matsubara Y, Narisawa K, Tada K, Prevalence of K329E mutation in the medium-chain acyl-CoA dehydrogenase gene determined from Guthrie cards. Lancet 1991; 338: 552-553
25. Kelly DP, Hale DE, Rutledge SL, Molecular basis of inherited medium-chain acyl-CoA dehydrogenase deficiency causing sudden child death. J Inherit Metab Dis 1992; 15: 171-180
26. Kelly DP, Mendelsohn NJ, Sobel BE, Bergmann SR Detection and assessment by positron emission tomography of a genetically determined defect in myocardial fatty acid utilization (long-chain acyl-CoA dehydrogenase deficiency). Am J Cardiol 1993; 71: 731-744
27. Wallace DC Diseases of the mitochondrial DNA. Annu Rev Biochem 1992; 61: 1175-1212
28. DiMauro S, Bonilla E, Zeviani M, Nakagawa M, DeVivo DC Mitochondrial myopathies. Ann Neurol 1985; 17: 521-538
29. Barth PG, Scholte HR, Berden JA, An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci 1983; 62: 327-355
30. Zeviani M, Gellera C, Antozzi C, Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA leu(UUR). Lancet 1991; 338: 143-147
31. Anderson S, Bankier AT, Barrell BG, Sequence and organization of the human mitochondrial genome. Nature 1981; 290: 457-465
32. Wallace DC, Ye JH, Neckelmann SN, Singh G, Webster KA, Greenberg BD Sequence analysis of cDNAs for the human and bovine ATP synthase β subunit: mitochondrial DNA genes sustain seventeen times more mutations. Curr Genet 1987; 12: 81-90
33. Wallace DC Mitotic segregation of mitochondrial DNAs in human cell hybrids and expression of chloramphenicol resistance. Somat Cell Mol Genet 1986; 12: 41-49
34. Cortopassi GA, Shibata D, Soong N-W, Arnheim N A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc Natl Acad Sci U S A 1992; 89: 7370-7374
35. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA, A., Suomalainen, A., Paetau, H., Leinonen, A., Majander, L., Peltonen, H., Somer, Lancet, (1992), 340, 1319-1320
36. Taniike M, Fukushima H, Yanagihara I, Mitochondrial tRNAIle mutation in fatal cardiomyopathy. Biochem Biophys Res Commun 1992; 186: 47-53
37. Ciro E, Nichols PF III, Maron BJ Heterogeneous morphologic expression of genetically transmitted hypertrophic cardiomyopathy: two-dimensional echocardiographic analysis. Circulation 1983; 67: 1227-1233
38. Maron BJ, Nichols PF III, Pickle LW, Wesley YE, Mulvihill JJ Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. Am J Cardiol 1984; 53: 1087-1094
39. Jarcho JA, McKenna W, Pare JAP, Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med 1989; 321: 1372-1378
40. Geisterfer-Lowrance AAT, Kass S, Tanigawa G, A molecular basis for familial hypertrophic cardiomyopathy: a b cardiac myosin heavy chain gene missense mutation. Cell 1990; 62: 999-1006
41. Watkins H, Rosenzweig A, Hwang D-S, Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992; 326: 1108-1114
42. Epstein ND, Cohn GM, Cyran F, Fananapazir L Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the β-myosin heavy chain gene: a 908Leu-to-Val mutation and a 403Arg-to-Gln mutation. Circulation 1992; 86: 345-352
43. Marian AJ, Kelly D, Mares A, The missense mutation in exon 13 of the β-myosin heavy chain gene, a genetic marker for sudden cardiac death in patients with familial hypertrophic cardiomyopathy. Circulation 1992; 86: Suppl I: I-16 abstract.
44. al-Mahdawi S, Chamberlain S, Cleland J, Identification of a mutation in the β cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy. Br Heart J 1993; 69: 136-141
45. Marian AJ, Yu Q-T, Mares A Jr, Hill R, Roberts R, Perryman MB Detection of a new mutation in the β-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy. J Clin Invest 1992; 90: 2156-2165
46. Fananapazir L, Epstein ND Genotype-phenotype correlations in hypertrophic cardiomyopathy. Circulation 1994; 89: 22-32
47. Watkins H, Thierfelder L, Hwang D-S, McKenna W, Seidman JG, Seidman CE Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations. J Clin Invest 1992; 90: 1666-1671
48. Solomon SD, Jarcho JA, McKenna W, Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease. J Clin Invest 1990; 86: 993-999
49. Epstein ND, Fananapazir L, Lin HJ, Evidence of genetic heterogeneity in five kindreds with familial hypertrophic cardiomyopathy. Circulation 1992; 85: 635-647
50. Schwartz K, Beckmann J, Dufour C, Exclusion of cardiac myosin heavy chain and actin gene involvement in hypertrophic cardiomyopathy of several French families. Circ Res 1992; 71: 3-8
51. Ko YL, Lien WP, Chen JJ, Wu CW, Tang TK, Liew CC No evidence for linkage of familial hypertrophic cardiomyopathy and chromosome 14q1 locus D14S26 in a Chinese family: evidence for genetic heterogeneity. Hum Genet 1992; 89: 597-601
52. Watkins H, MacRae C, Thierfelder L, A disease locus for familial hypertrophic cardiomyopathy maps to chromosome lq3. Nat Genet 1993; 3: 333-337
53. Thierfelder L, MacRae C, Watkins H, A familial hypertrophic cardiomyopathy locus maps to chromosome l5q2. Proc Natl Acad Sci U S A 1993; 90: 6270-6274
54. Carrier L, Hengstenberg C, Beckmann JS, Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nat Genet 1993; 4: 311-313
55. Cuda G, Fananapazir L, Zhu W-S, Sellers JR, Epstein ND Skeletal muscle expression and abnormal function of β-myosin in hypertrophic cardiomyopathy. J Clin Invest 1993; 91: 2861-2865
56. Mastaglia FL, Walton J, eds. Skeletal muscle pathology. Edinburgh, Scotland: Churchill Livingstone, 1982.
57. Perloff JK, de Leon AC Jr, O'Doherty D The cardiomyopathy of progressive muscular dystrophy. Circulation 1966; 33: 625-648
58. Nigro G, Comi LI, Politano L, Bain RJI The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 1990; 26: 271-277
59. Hoffman EP, Brown RH Jr, Kunkel LM Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51: 919-928
60. Hoffman EP, Fischbeck KH, Brown RH, Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med 1988; 318: 1363-1368
61. Towbin JA, Hejtmancik JF, Brink P, X-linked dilated cardiomyopathy: molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 1993; 87: 1854-1865
62. Muntoni F, Cau M, Ganau A, Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med 1993; 329: 921-925
63. Ervasti JM, Campbell KP Membrane organization of the dystrophin-glycoprotein complex. Cell 1991; 66: 1121-1131
64. Arahata K, Ishiura S, Ishiguro T, Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 1988; 333: 861-863
65. Bies RD, Friedman D, Roberts R, Perryman MB, Caskey CT Expression and localization of dystrophin in human cardiac Purkinje fibers. Circulation 1992; 86: 147-153